These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 31632488)
21. LncRNA CCND2-AS1 promotes proliferation, migration, and invasion in papillary thyroid carcinoma. Xia E; Bhandari A; Shen Y; Zhou X; Sindan N; Xiang J; Guan Y; Yang F; Wang O Biochem Biophys Res Commun; 2018 Feb; 496(2):628-632. PubMed ID: 29366479 [TBL] [Abstract][Full Text] [Related]
22. LINC00511 influences cellular proliferation through cyclin-dependent kinases in papillary thyroid carcinoma. Xiang J; Guan Y; Bhandari A; Xia E; Wen J; Wang O J Cancer; 2020; 11(2):450-459. PubMed ID: 31897240 [No Abstract] [Full Text] [Related]
23. LncRNA MCM3AP-AS1 promotes proliferation and invasion through regulating miR-211-5p/SPARC axis in papillary thyroid cancer. Liang M; Jia J; Chen L; Wei B; Guan Q; Ding Z; Yu J; Pang R; He G Endocrine; 2019 Aug; 65(2):318-326. PubMed ID: 31030335 [TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis. Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764 [TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA BRM promotes proliferation and invasion of papillary thyroid carcinoma by regulating the microRNA-331-3p/SLC25A1 axis. Liu S; Zhang D; Chen L; Gao S; Huang X Oncol Lett; 2020 Apr; 19(4):3071-3078. PubMed ID: 32218861 [TBL] [Abstract][Full Text] [Related]
26. LncRNA PTCSC3/miR-574-5p Governs Cell Proliferation and Migration of Papillary Thyroid Carcinoma via Wnt/β-Catenin Signaling. Wang X; Lu X; Geng Z; Yang G; Shi Y J Cell Biochem; 2017 Dec; 118(12):4745-4752. PubMed ID: 28513866 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells. Song HM; Luo Y; Li DF; Wei CK; Hua KY; Song JL; Xu H; Maskey N; Fang L Int J Clin Exp Pathol; 2015; 8(9):9889-900. PubMed ID: 26617698 [TBL] [Abstract][Full Text] [Related]
28. Knockdown of lncRNA UCA1 inhibits proliferation and invasion of papillary thyroid carcinoma through regulating miR-204/IGFBP5 axis. Liu H; Li R; Guan L; Jiang T Onco Targets Ther; 2018; 11():7197-7204. PubMed ID: 30425512 [TBL] [Abstract][Full Text] [Related]
29. Cervical carcinoma high-expressed long non-coding RNA 1 promotes papillary thyroid carcinoma cell proliferation and invasion. Shi P; Liu Y; Zhang M; Yang J; Jing S; Yang D; Liu F; Wu Y; Shi H; Geng C Transl Cancer Res; 2021 Sep; 10(9):4158-4168. PubMed ID: 35116712 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-335 is downregulated in papillary thyroid cancer and suppresses cancer cell growth, migration and invasion by directly targeting ZEB2. Kan Q; Su Y; Yang H Oncol Lett; 2017 Dec; 14(6):7622-7628. PubMed ID: 29344210 [TBL] [Abstract][Full Text] [Related]
31. LncRNA NORAD promotes thyroid carcinoma progression through targeting miR-202-5p. He H; Yang H; Liu D; Pei R Am J Transl Res; 2019; 11(1):290-299. PubMed ID: 30787987 [TBL] [Abstract][Full Text] [Related]
32. Long Noncoding RNA LINC00460 Modulates MMP-9 to Promote Cell Proliferation, Invasion and Apoptosis by Targeting miR-539 in Papillary Thyroid Cancer. Zou X; Guo ZH; Li Q; Wang PS Cancer Manag Res; 2020; 12():199-207. PubMed ID: 32021436 [TBL] [Abstract][Full Text] [Related]
33. LncRNA GAS8-AS1 inhibits cell proliferation through ATG5-mediated autophagy in papillary thyroid cancer. Qin Y; Sun W; Zhang H; Zhang P; Wang Z; Dong W; He L; Zhang T; Shao L; Zhang W; Wu C Endocrine; 2018 Mar; 59(3):555-564. PubMed ID: 29327301 [TBL] [Abstract][Full Text] [Related]
34. MiR-3121-3p promotes tumor invasion and metastasis by suppressing Rap1GAP in papillary thyroid cancer Xu M; Zhou J; Zhang Q; Le K; Xi Z; Yi P; Zhao X; Tan J; Huang T Ann Transl Med; 2020 Oct; 8(19):1229. PubMed ID: 33178761 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-7 inhibits proliferation, migration and invasion of thyroid papillary cancer cells via targeting CKS2. Hua K; Jin J; Zhang H; Zhao B; Wu C; Xu H; Fang L Int J Oncol; 2016 Oct; 49(4):1531-1540. PubMed ID: 27633373 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA-675 directly targets MAPK1 to suppress the oncogenicity of papillary thyroid cancer and is sponged by long non-coding RNA RMRP. Wang J; Xiao T; Zhao M Onco Targets Ther; 2019; 12():7307-7321. PubMed ID: 31564913 [TBL] [Abstract][Full Text] [Related]
37. MiR-381-3p inhibits proliferation, migration and invasion by targeting LRP6 in papillary thyroid carcinoma. Kong W; Yang L; Li PP; Kong QQ; Wang HY; Han GX; Wang QB Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3804-3811. PubMed ID: 29949156 [TBL] [Abstract][Full Text] [Related]
38. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma. Meng XF; Zhao LY; Chu XF Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752 [TBL] [Abstract][Full Text] [Related]
39. LncRNA TUG1 influences papillary thyroid cancer cell proliferation, migration and EMT formation through targeting miR-145. Lei H; Gao Y; Xu X Acta Biochim Biophys Sin (Shanghai); 2017 Jul; 49(7):588-597. PubMed ID: 28645161 [TBL] [Abstract][Full Text] [Related]
40. Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis. Xia S; Wang C; Postma EL; Yang Y; Ni X; Zhan W Onco Targets Ther; 2017; 10():1743-1755. PubMed ID: 28367057 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]